BioAtla, Inc. / Fundamentals
Income statement
- Net revenue
€9.48M - Cost of goods sold
€99.08K - Gross profit
€9.38M - SG&A expenses
€17.83M - R&D expenses
€46.60M - EBITDA
-€54.39M - D&A
€649.61K - EBIT
-€54.95M - Interest expenses
€0.00 - EBT
-€51.28M - Tax expenses
€0.00 - Net income
-€51.28M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€2.06M - Changes in working capital
€1.45M - Operating cash flow
-€45.08M - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
€0.00 - Total cash dividends paid
€0.00 - Issuance of common stock
-€210.22K - Debt repayment
€0.00 - Other financing cash flow
€7.60M - Net financing cash flow
€7.64M - Foreign exchange effects
€0.00 - Net change in cash
-€37.44M - Cash at end of period
€15.69M - Free cash flow
-€45.08M
Balance sheet
- Cash and cash equivalents
€15.69M - Cash and short-term investments
€15.69M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€2.07M - Total current assets
€17.76M - Property, plant & equipment
€5.47M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€140.43K - Total non-current assets
€5.61M - Total assets
€23.37M - Accounts payable
€4.00M - Short-term debt
€1.39M - Other current liabilities
€8.91M - Total current liabilities
€14.30M - Long-term debt
€9.03M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€18.98M - Total non-current liabilities
€23.50M - Total liabilities
€37.80M - Common stock
€5.17K - Retained earnings
-€448.08M - Other equity
€0.00 - Total equity
-€14.43M - Total liabilities and shareholders' equity
€23.37M
Company information
- Market capitalization
€19.13M - Employees
61 - Enterprise Value
-€4.78M
Company ratios
- Gross margin
-
99.0% Much better than peer group: -848.0% - EBITDA margin
-
-574.0% Much better than peer group: -6,328.1% - EBIT margin
-
-579.8% Much better than peer group: -6,468.4% - EBT margin
-
-541.0% Much better than peer group: -6,152.6% - Net margin
-
-541.0% Much better than peer group: -6,084.2% - ROE
-
355.4% Much better than peer group: -441.2% - ROA
-
-219.4% Much worse than peer group: -114.2% - Asset turnover
-
40.5% Better than peer group: 20.9% - FCF margin
-
-475.7% Much better than peer group: -5,352.6% - FCF yield
-235.6% - Efficiency ratio
674.0% - Net sales per employee
-
€155.36K - Net income per employee
-
-€840.58K